DOCSLIB.ORG

Exempt Diagnoses for Ambulatory Visit Limitation

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Exempt Diagnoses for Ambulatory Visit Limitation Exempt Diagnoses for Ambulatory Visit Limitation Diagnosis Description Code V20.2 Routine infant or child health check V22.0 Supervision of normal first pregnancy V22.1 Supervision of other normal pregnancy V22.2 Pregnant state, incidental V23.0 Pregnancy with history of infertility V23.1 Pregnancy with history of trophoblastic disease V23.3 Grand multiparity V23.41 Pregnancy with history of pre-term labor V23.49 Pregnancy with other poor obstretric history V23.5 Pregnancy with other poor reproductive history V23.7 Insufficient prenatal care V23.81 Elderly primigravida V23.82 Elderly multigravida V23.83 Young primigravida V23.84 Young multigravida V23.89 Other high-risk pregnancy V23.9 Unspecified high-risk pregnancy V56.0 Encounter for extracorporeal dialysis V56.8 Encounter for other dialysis V58.0 Encounter for radiotherapy V58.11 Encounter for antineoplastic chemotherapy V58.61 Long-term (current) use of anticoagulants V72.6 Laboratory examination 042 HIV disease 054.40 Herpes simplex with unspecified ophthalmic complication 054.41 Herpes simplex dermatitis of eyelid 054.42 Dendritic keratitis 054.43 Herpes simplex disciform keratitis 054.44 Herpes simplex iridocyclitis 054.49 Herpes simplex with ophthalmic complications, other 070.0 Viral hepatitis A with hepatic coma 070.1 Viral hepatitis A without mention of hepatic coma 070.20 Viral hepatitis B with hepatic coma; acute or unspecified, without mention of hepatitis delta 070.21 Viral hepatitis B with hepatic coma; acute or unspecified with hepatitis delta 070.30 Viral hepatitis B without mention of hepatic coma; acute or unspecified, without mention of hepatitis delta 070.31 Viral hepatitis B without mention of hepatic coma; acute or unspecified with hepatitis delta 070.41 Acute hepatitis C with hepatic coma 070.42 Hepatitis delta without mention of active hepatitis B disease with hepatic coma 070.43 Hepatitis E with hepatic coma 070.44 Chronic hepatitis C with hepatic coma 070.49 Other specified viral hepatitis with hepatic coma 070.51 Acute hepatitis C without mention of hepatic coma 140.0 Malignant Neoplasms through 208.91 250.10 Diabetes with ketoacidosis; type II or unspecified type, not stated as uncontrolled 250.11 Diabetes with ketoacidosis; type I (juvenile type), not stated as uncontrolled 250.12 Diabetes with ketoacidosis; type II or unspecified type, uncontrolled 250.13 Diabetes with ketoacidosis; type I (juvenile type), uncontrolled 250.20 Diabetes with hyperosmolarity; type II or unspecified type, not stated as uncontrolled 250.21 Diabetes with hyperosmolarity; type I (juvenile type), not stated as uncontrolled 10/1/08 1 Exempt Diagnoses for Ambulatory Visit Limitation Diagnosis Description Code 250.22 Diabetes with hyperosmolarity; type II or unspecified type, uncontrolled 250.23 Diabetes with hyperosmolarity; type I (juvenile type), uncontrolled 250.30 Diabetes with other coma; type II or unspecified type, not stated as uncontrolled 250.31 Diabetes with other coma; type I (juvenile type), not stated as uncontrolled 250.32 Diabetes with other coma; type II or unspecified type, uncontrolled 250.33 Diabetes with other coma; type I (juvenile type), uncontrolled 250.60 Diabetes with neurological manifestations; type II or unspecified type, not stated as uncontrolled 250.61 Diabetes with neurological manifestations; type I (juvenile type), not stated as uncontrolled 250.62 Diabetes with neurological manifestations; type II or unspecified type, uncontrolled 250.63 Diabetes with neurological manifestations; type I (juvenile type), uncontrolled 250.70 Diabetes with peripheral cirulatory disorders; type II or unspecified type, not stated as uncontrolled 250.71 Diabetes with peripheral cirulatory disorders; type I (juvenile type), not stated as uncontrolled 250.72 Diabetes with peripheral cirulatory disorders; type II or unspecified type, uncontrolled 250.73 Diabetes with peripheral cirulatory disorders; type I (juvenile type), uncontrolled 277.00 Cystic fibrosis without mention of meconium ileus 277.01 Cystic fibrosis with meconium ileus 277.02 Cystic fibrosis with pulmonary manifestations 277.03 Cystic fibrosis with gastrointestinal manifestations 282.41 Sickle-cell thalassemia without crisis 282.42 Sickle-cell thalassemia with crisis 282.49 Other thalassemia 282.60 Sickle-cell disease, unspecified 282.61 Hb-SS disease without crisis 282.62 Hb-SS disease with crisis 282.63 Sickle-cell/Hb-C disease without crisis 282.64 Sickle-cell/Hb-C disease with crisis 282.68 Other sickle-cell disease without crisis 282.69 Other sickle-cell disease with crisis 286.0 Congenital factor VIII disorder 286.1 Congenital factor IX disorder 286.2 Congenital factor XI deficiency 286.3 Congenital deficiency of other clotting factors 286.4 von Willebrand's disease 286.5 Hemorrhagic disease due to intrinsic circulating anticoagulants 286.6 Defibrination syndrome 286.7 Acquired coagulation factor deficiency 295.01 Schizophrenic disorders, simple type; subchronic 295.02 Schizophrenic disorders, simple type; chronic 295.03 Schizophrenic disorders, simple type; subchronic with acute exacerabation 295.04 Schizophrenic disorders, simple type; chronic with acute exacerbation 295.11 Schizophrenic disorders, disorganized type; subchronic 295.12 Schizophrenic disorders, disorganized type; chronic 295.13 Schizophrenic disorders, disorganized type subchronic with acute exacerbation 295.14 Schizophrenic disorders, disorganized type; chronic with acute exacerbation 295.21 Schizophrenic disorders, catatonic type; subchronic 295.22 Schizophrenic disorders, catatonic type; chronic 295.23 Schizophrenic disorders, catatonic type subchronic with acute exacerbation 295.24 Schizophrenic disorders, catatonic type; chronic with acute exacerbation 295.31 Schizophrenic disorders, paranoid type; subchronic 295.32 Schizophrenic disorders, paranoid type; chronic 295.33 Schizophrenic disorders, paranoid type subchronic with acute exacerbation 295.34 Schizophrenic disorders, paranoid type; chronic with acute exacerbation 295.41 Schizophreniform disorder; subchronic 10/1/08 2 Exempt Diagnoses for Ambulatory Visit Limitation Diagnosis Description Code 295.42 Schizophreniform disorder; chronic 295.43 Schizophreniform disorder; subchronic with acute exacerbation 295.44 Schizophreniform disorder; chronic with acute exacerbation 295.51 Latent Schizophrenia; subchronic 295.52 Latent Schizophrenia; chronic 295.53 Latent Schizophrenia; subchronic with acute exacerbation 295.54 Latent Schizophrenia; chronic with acute exacerbation 295.61 Schizophrenic disorders, residual type; subchronic 295.62 Schizophrenic disorders, residual type; chronic 295.63 Schizophrenic disorders, residual type; subchronic with acute exacerbation 295.64 Schizophrenic disorders, residual type; chronic with acute exacerbation 295.71 Schizoaffective disorder; subchronic 295.72 Schizoaffective disorder; chronic 295.73 Schizoaffective disorder; subchronic with acute exacerbation 295.74 Schizoaffective disorder; chronic with acute exacerbation 295.81 Other specified types of schizophrenia; subchronic 295.82 Other specified types of schizophrenia; chronic 295.83 Other specified types of schizophrenia; subchronic with acute exacerbation 295.84 Other specified types of schizophrenia; chronic with acute exacerbation 295.91 Unspecified schizophrenia; subchronic 295.92 Unspecified schizophrenia; chronic 295.93 Unspecified schizophrenia; subchronic with acute exacerbation 295.94 Unspecified schizophrenia; chronic with acute exacerbation 296.03 Bipolar I disorder, single manic episode; severe, without mention of psychotic behavior 296.04 Bipolar I disorder, single manic episode; severe, specified as with psychotic behavior 296.13 Manic disorder, recurrent episode; severe, without mention of psychotic behavior 296.14 Manic disorder, recurrent episode; severe, specified as with psychotic behavior 296.23 Major depressive disorder, single episode; severe, without mention of psychotic behavior 296.24 Major depressive disorder, single episode; severe, specified as with psychotic behavior 296.33 Major depressive disorder, recurrent episode; severe, without mention of psychotic behavior 296.34 Major depressive disorder, recurrent episode; severe, specified as with psychotic behavior 296.43 Bipolar I disorder, most recent episode (or current) manic; severe, without mention of psychotic behavior 296.44 Bipolar I disorder, most recent episode (or current) manic; severe, specified as with psychotic behavior 296.53 Bipolar I disorder, most recent episode (or current) depressed; severe, without mention of psychotic behavior 296.54 Bipolar I disorder, most recent episode (or current) depressed; severe, specified as with psychotic behavior 296.63 Bipolar I disorder, most recent episode (or current) mixed; severe, without mention of psychotic behavior 296.64 Bipolar I disorder, most recent episode (or current) mixed; severe, specified as with psychotic behavior 356.1 Peroneal muscular atrophy 356.8 Other specified idiopathic peripheral neuropathy 357.2 Polyneuropathy in diabetes 361.00 Retinal detachment with retinal defect, unspecified 361.01 Retinal detachment with retinal defect, recent detachment, partial, with single defect 361.02 Retinal detachment with retinal defect, recent detachment, partial, with multiple defects 361.03 Retinal detachment with retinal defect, recent detachment, partial, with giant tear 361.04 Retinal detachment with retinal defect, recent detachment, partial, with retinal dialysis 361.05 Retinal detachment with retinal defect, recent detachment, total
Load more

Recommended publications
  • The Diagnostic Impact of Limited, Screening Obstetric Ultrasound When Performed by Midwives in Rural Uganda
    Journal of Perinatology (2014) 34, 508–512 © 2014 Nature America, Inc. All rights reserved 0743-8346/14 www.nature.com/jp ORIGINAL ARTICLE The diagnostic impact of limited, screening obstetric ultrasound when performed by midwives in rural Uganda JO Swanson1, MG Kawooya2, DL Swanson1, DS Hippe1, P Dungu-Matovu2 and R Nathan1 OBJECTIVE: To evaluate the diagnostic impact of limited obstetric ultrasound (US) in identifying high-risk pregnancies when used as a screening tool by midwives in rural Uganda. STUDY DESIGN: This was an institutional review board-approved prospective study of expecting mothers in rural Uganda who underwent clinical and US exams as part of their standard antenatal care visit in a local health center in the Isingiro district of Uganda. The midwives documented clinical impressions before performing a limited obstetric US on the same patient. The clinical findings were then compared with the subsequent US findings to determine the diagnostic impact. The midwives were US-naive before participating in the 6-week training course for limited obstetric US. RESULT: Midwife-performed screening obstetric US altered the clinical diagnosis in up to 12% clinical encounters. This diagnostic impact is less (6.7 to 7.4%) if the early third trimester diagnosis of malpresentation is excluded. The quality assurance review of midwives’ imaging demonstrated 100% sensitivity and specificity in the diagnosing gestational number, and 90% sensitivity and 96% specificity in the diagnosis of fetal presentation. CONCLUSION: Limited, screening obstetric US performed by midwives with focused, obstetric US training demonstrates the diagnostic impact for identifying conditions associated with high-risk pregnancies in 6.7 to 12% of patients screened.
    [Show full text]
  • Breech Presentation at Delivery: a Marker for Congenital Anomaly?
    Journal of Perinatology (2014) 34, 11–15 & 2014 Nature America, Inc. All rights reserved 0743-8346/14 www.nature.com/jp ORIGINAL ARTICLE Breech presentation at delivery: a marker for congenital anomaly? D Mostello1, JJ Chang2, F Bai2, J Wang3, C Guild4, K Stamps2 and TL Leet2,{ OBJECTIVE: To determine whether congenital anomalies are associated with breech presentation at the time of birth. STUDY DESIGN: A population-based, retrospective cohort study was conducted among 460 147 women with singleton live births using the Missouri Birth Defects Registry, which includes all defects diagnosed during the first year of life. Maternal and obstetric characteristics and outcomes between breech and cephalic presentation groups were compared using w2-square statistic and Student’s t-test. Multivariable binary logistic regression analysis was used to estimate adjusted odds ratios (aORs) and 95% confidence intervals (CIs). RESULT: At least one congenital anomaly was more likely present among infants breech at birth (11.7%) than in those with cephalic presentation (5.1%), whether full-term (9.4 vs 4.6%) or preterm (20.1 vs 11.6%). The relationship between breech presentation and congenital anomaly was stronger among full-term births (aOR 2.09, CI 1.96, 2.23, term vs 1.40, CI 1.26, 1.55, preterm), but not in all categories of anomalies. CONCLUSION: Breech presentation at delivery is a marker for the presence of congenital anomaly. Infants delivered breech deserve special scrutiny for the presence of malformation. Journal of Perinatology (2014) 34, 11–15;
    [Show full text]
  • A Guide to Obstetrical Coding Production of This Document Is Made Possible by Financial Contributions from Health Canada and Provincial and Territorial Governments
    ICD-10-CA | CCI A Guide to Obstetrical Coding Production of this document is made possible by financial contributions from Health Canada and provincial and territorial governments. The views expressed herein do not necessarily represent the views of Health Canada or any provincial or territorial government. Unless otherwise indicated, this product uses data provided by Canada’s provinces and territories. All rights reserved. The contents of this publication may be reproduced unaltered, in whole or in part and by any means, solely for non-commercial purposes, provided that the Canadian Institute for Health Information is properly and fully acknowledged as the copyright owner. Any reproduction or use of this publication or its contents for any commercial purpose requires the prior written authorization of the Canadian Institute for Health Information. Reproduction or use that suggests endorsement by, or affiliation with, the Canadian Institute for Health Information is prohibited. For permission or information, please contact CIHI: Canadian Institute for Health Information 495 Richmond Road, Suite 600 Ottawa, Ontario K2A 4H6 Phone: 613-241-7860 Fax: 613-241-8120 www.cihi.ca [email protected] © 2018 Canadian Institute for Health Information Cette publication est aussi disponible en français sous le titre Guide de codification des données en obstétrique. Table of contents About CIHI ................................................................................................................................. 6 Chapter 1: Introduction ..............................................................................................................
    [Show full text]
  • Twin Pregnancy with Triploidy and Co-Existing Live Twin Progressing to Viability: Case Study and Literature Review
    Obstetrics & Gynecology International Journal Case Report Open Access Twin pregnancy with triploidy and co-existing live twin progressing to viability: Case study and literature review Abstract Volume 9 Issue 4 - 2018 Background: Twin pregnancies consisting of a triploid fetus with molar change and a 1,2 1,2 1,2 healthy coexisting fetus is an extremely rare phenomenon. Triploidy rarely advances to the Cingiloglu P, Yeung T, Sekar R second trimester, most resulting in a miscarriage, termination or stillbirth. Only five cases 1Royal Brisbane and Women’s Hospital, Women’s and Newborn of a triploid fetus and a healthy co-twin have been reported in literature. We present the first Services, Australia documented case of a live delivery of both triploid fetus and coexisting viable twin. 2University of Queensland, Australia Case presentation: A 23-year old woman, gravida 2, para 1 was admitted at 26+4 weeks Correspondence: Pinar Cingiloglu, Women’s and Newborn gestation with DCDA twins and a shortened cervix. Sonography revealed polyhydramnios, Services, Royal Brisbane and Women’s Hospital, Bowen Bridge an abnormal cystic placenta, and small aortic valve for the presenting twin. Emergency Road&, Butterfield St, Herston Queensland Australia, Tel +61 caesarean section was performed at 28 weeks gestation for cord prolapse. Twin A was born (07) 3646 8111, Email [email protected] a live infant with ambiguous genitalia, syndactyly, epicanthic folds and cerebral cysts. Twin B was born a healthy live male. Histopathology revealed features consistent with Received: June 13, 2018 | Published: July 13, 2018 partial hydatidiform mole, and cytogenetics revealed a diandric triploidy in twin A.
    [Show full text]
  • Gtg-No-20B-Breech-Presentation.Pdf
    Guideline No. 20b December 2006 THE MANAGEMENT OF BREECH PRESENTATION This is the third edition of the guideline originally published in 1999 and revised in 2001 under the same title. 1. Purpose and scope The aim of this guideline is to provide up-to-date information on methods of delivery for women with breech presentation. The scope is confined to decision making regarding the route of delivery and choice of various techniques used during delivery. It does not include antenatal or postnatal care. External cephalic version is the topic of a separate RCOG Green-top Guideline No. 20a: ECV and Reducing the Incidence of Breech Presentation. 2. Background The incidence of breech presentation decreases from about 20% at 28 weeks of gestation to 3–4% at term, as most babies turn spontaneously to the cephalic presentation. This appears to be an active process whereby a normally formed and active baby adopts the position of ‘best fit’ in a normal intrauterine space. Persistent breech presentation may be associated with abnormalities of the baby, the amniotic fluid volume, the placental localisation or the uterus. It may be due to an otherwise insignificant factor such as cornual placental position or it may apparently be due to chance. There is higher perinatal mortality and morbidity with breech than cephalic presentation, due principally to prematurity, congenital malformations and birth asphyxia or trauma.1,2 Caesarean section for breech presentation has been suggested as a way of reducing the associated perinatal problems2,3 and in many countries in Northern Europe and North America caesarean section has become the normal mode of breech delivery.
    [Show full text]
  • Advising Women with Diabetes in Pregnancy to Express Breastmilk In
    Articles Advising women with diabetes in pregnancy to express breastmilk in late pregnancy (Diabetes and Antenatal Milk Expressing [DAME]): a multicentre, unblinded, randomised controlled trial Della A Forster, Anita M Moorhead, Susan E Jacobs, Peter G Davis, Susan P Walker, Kerri M McEgan, Gillian F Opie, Susan M Donath, Lisa Gold, Catharine McNamara, Amanda Aylward, Christine East, Rachael Ford, Lisa H Amir Summary Lancet 2017; 389: 2204–13 Background Infants of women with diabetes in pregnancy are at increased risk of hypoglycaemia, admission to a See Editorial page 2163 neonatal intensive care unit (NICU), and not being exclusively breastfed. Many clinicians encourage women with See Comment page 2167 diabetes in pregnancy to express and store breastmilk in late pregnancy, yet no evidence exists for this practice. We Judith Lumley Centre, School of aimed to determine the safety and efficacy of antenatal expressing in women with diabetes in pregnancy. Nursing and Midwifery, La Trobe University, Methods We did a multicentre, two-group, unblinded, randomised controlled trial in six hospitals in Victoria, Australia. Melbourne, VIC, Australia (Prof D A Forster PhD, We recruited women with pre-existing or gestational diabetes in a singleton pregnancy from 34 to 37 weeks’ gestation A M Moorhead RM, and randomly assigned them (1:1) to either expressing breastmilk twice per day from 36 weeks’ gestation (antenatal L H Amir PhD); Royal Women’s expressing) or standard care (usual midwifery and obstetric care, supplemented by support from a diabetes educator). Hospital, Parkville, VIC, Randomisation was done with a computerised random number generator in blocks of size two and four, and was Australia (Prof D A Forster, A M Moorhead, S E Jacobs MD, stratified by site, parity, and diabetes type.
    [Show full text]
  • External Cephalic Version (Ecv) Author: Scope
    Sponsor: Woman, Child and Youth Name: External Cephalic Version MATERNITY UNIT GUIDELINE: EXTERNAL CEPHALIC VERSION (ECV) AUTHOR: Consultant Obstetrician SCOPE: All obstetricians and midwives working in maternity. PURPOSE: To inform all health professions of the assessment criteria and procedure for an ECV. ECV is a procedure to rotate the fetus from a breech or transverse DEFINITIONS: presentation to a cephalic presentation by external manipulation of the mother’s abdomen INDICATIONS: Should be offered to women with a non-cephalic fetal lie to improve their chance of a vaginal cephalic birth ABSOLUTE Significant uterine anomaly (eg. bicornuate uterus); Indications for caesarean birth irrespective of fetal presentation; CONTRAINDICATIONS Antepartum haemorrhage; Placenta praevia; Severe maternal cardiac disease; Ruptured membranes (given risk of cord prolapse could be considered in theatre) Abnormal fetal monitoring suggestive of fetal hypoxia; Hyper-extended fetal head; Significant fetal anomaly (eg. hydrocephaly); Abruptio placenta; Fetal growth restriction (severe and/or abnormal dopplers); Multiple pregnancy – though may be considered for the second twin after birth of the first twin. RELATIVE Previous caesarean birth; CONTRAINDICATIONS Previous uterine surgery; Maternal obesity; Fetal growth restriction (mild with normal dopplers); Decreased liquor volume; Severe pregnancy induced hypertension; Established labour; Factors Decreasing Success Nulliparity Rates Anterior, lateral or cornual placenta Decreased amniotic
    [Show full text]
  • Obstetrics Seventh Edition
    PROLOGObstetrics seventh edition The American College of Obstetricians and Gynecologists WOMEN’S HEALTH CARE PHYSICIANS Obstetrics seventh edition Assessment Book The American College of Obstetricians and Gynecologists WOMEN’S HEALTH CARE PHYSICIANS ISBN 978-1-934984-22-2 Copyright 2013 by the American College of Obstetricians and Gynecologists. All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, posted on the Internet, or transmitted, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise, without the prior written permission of the publisher. 12345/76543 The American College of Obstetricians and Gynecologists 409 12th Street, SW PO Box 96920 Washington, DC 20090-6920 Contributors PROLOG Editorial and Advisory Committee CHAIR MEMBERS Ronald T. Burkman Jr, MD Bernard Gonik, MD Professor of Obstetrics and Professor and Fann Srere Chair of Gynecology Perinatal Medicine Tufts University School of Medicine Division of Maternal–Fetal Medicine Division of General Obstetrics and Department of Obstetrics and Gynecology Gynecology Department of Obstetrics and Wayne State University School of Gynecology Medicine Baystate Medical Center Detroit, Michigan Springfield, Massachusetts Louis Weinstein, MD Past Paul A. and Eloise B. Bowers Professor and Chair Department of Obstetrics and Gynecology Thomas Jefferson University Philadelphia, Pennsylvania Linda Van Le, MD Leonard Palumbo Distinguished Professor UNC Gynecologic Oncology University of North Carolina School of Medicine Chapel Hill, North Carolina PROLOG Task Force for Obstetrics, Seventh Edition COCHAIRS MEMBERS Vincenzo Berghella, MD Cynthia Chazotte, MD Director, Division of Maternal–Fetal Professor of Clinical Obstetrics and Medicine Gynecology and Women’s Health Professor, Department of Obstetrics Department of Obstetrics and Gynecology and Gynecology Weiler Hospital of the Albert Einstein Thomas Jefferson University College of Medicine Philadelphia, Pennsylvania Bronx, New York George A.
    [Show full text]
  • Pretest Obstetrics and Gynecology
    Obstetrics and Gynecology PreTestTM Self-Assessment and Review Notice Medicine is an ever-changing science. As new research and clinical experience broaden our knowledge, changes in treatment and drug therapy are required. The authors and the publisher of this work have checked with sources believed to be reliable in their efforts to provide information that is complete and generally in accord with the standards accepted at the time of publication. However, in view of the possibility of human error or changes in medical sciences, neither the authors nor the publisher nor any other party who has been involved in the preparation or publication of this work warrants that the information contained herein is in every respect accurate or complete, and they disclaim all responsibility for any errors or omissions or for the results obtained from use of the information contained in this work. Readers are encouraged to confirm the information contained herein with other sources. For example and in particular, readers are advised to check the prod- uct information sheet included in the package of each drug they plan to administer to be certain that the information contained in this work is accurate and that changes have not been made in the recommended dose or in the contraindications for administration. This recommendation is of particular importance in connection with new or infrequently used drugs. Obstetrics and Gynecology PreTestTM Self-Assessment and Review Twelfth Edition Karen M. Schneider, MD Associate Professor Department of Obstetrics, Gynecology, and Reproductive Sciences University of Texas Houston Medical School Houston, Texas Stephen K. Patrick, MD Residency Program Director Obstetrics and Gynecology The Methodist Health System Dallas Dallas, Texas New York Chicago San Francisco Lisbon London Madrid Mexico City Milan New Delhi San Juan Seoul Singapore Sydney Toronto Copyright © 2009 by The McGraw-Hill Companies, Inc.
    [Show full text]
  • MR Imaging of the Fetus in Utero II: a Practical Guide to Systematic Analysis - …
    MR Imaging of the Fetus in utero II: A Practical Guide to Systematic Analysis - ….. and the rest (non-CNS) A Robinson, S Blaser, S Pantazi, A Toi, D Chitayat, M Gundogan, G Ryan The Hospital for Sick Children Departments of Diagnostic Imaging and Clinical & Metabolic Genetics Mount Sinai Hospital Departments of Medical Imaging, Prenatal Diagnosis & Medical Genetics and Obstetrics & Gynaecology The University of Toronto, Ontario, Canada Purpose Biometry (see CNS poster) Check situs – work out which side is fetal left/right BEFORE checking internal organs Check the kidneys & bladder Most of our examinations are performed for CNS indications, with which most neuroradiologists should feel comfortable. However these examinations also include a variable amount of non-CNS anatomy with which neuroradiologists might feel less comfortable, but which should be reviewed routinely also, and not simply glossed over or even worse ignored. Materials and Methods Retrospective analysis of was performed in over 190 consecutive fetal MR examinations performed for CNS and non- CNS indications. Analysis included, but was not limited to, evaluation of thoracic and abdominal situs, lung parenchyma, diaphragms, liver and gallbladder, stomach, kidneys (including biometry), bladder, cord insertion, cord vessels, placental site and morphology, and amniotic fluid volume. Abdominal circumference Normal situs Normal levocardia Normal aortic arch Normal kidneys - axial Multicystic dysplastic kidneys Normal kidneys - sagittal Horseshoe kidney Conclusion Correct level
    [Show full text]
  • Physiological and Pathological Control of Fetal Heart Rate Patterns
    Cardiotocography – Physiological and Pathological Control of Fetal Heart Rate Patterns Terence Lao Department of Obstetrics & Gynaecology, Queen Mary Hospital, The University of Hong Kong Cardiotocography • A continuous recording of the fetal heart rate and uterine activities by electronic means • Limitations in its usefulness is related to – Problems with the monitors – Lack of understanding of pathophysiology – Carelessness / laziness in the attendants Basic Understanding of the Fetal Heart Rate Patterns • Represents fetal physiology • Different patterns represent the different results of the interaction of many factors • Fetal compromise only diagnosed in association with clinical assessment and interpreted with respect to the probability of fetal compromise Fetal Response to Hypoxia (1) Hypoxia ←↓Blood Flow ↓↓ ↓ PO2 ↑PCO2 ↓↓ Metabolic acidosis ← Respiratory acidosis ⇓ Redistribution of blood flow to vital organs Bradycardia, and slightly ↓cardiac output ↓oxygen consumption Fetal Response to Hypoxia (2) ↓↓ FHR variability FHR ↓ variability, retained / ↑ rate decelerations ⇓⇓ Compensated State Decompensated State (Normal cortical functions (Decrease cerebral cerebral oxygenation oxygenation, eventual maintained, can last up cellular damage to 60 min in experimental animals) Umbilical blood flow and hypoxia • Acute moderate hypoxia → no effect • Severe moderate hypoxia →↓due to myocardial depression, catecholamines What is Fetal Distress (1) ? = Hypoxaemia (low PO2) ? = Acidaemia (low pH) ? = General depression (low Apgar Score) But-
    [Show full text]
  • The Physiology of the Uterus in Labor
    The Physiology of the Uterus in Labor D. N. DANFORTH, M.D., R. J. GRAHAM, B.M. and A. C. IVY, M.D.l HE purpose of this article is to uterine horns (8). This ring becomes T synthesize into a rather complete fairly evident during labor at the junc­ picture the experimental observations tion of the upper and lower segments. that have been made during the past It is a more or less definite, tapering ten years in our laboratory regarding ledge, the formation of which is due the processes concerned in the evacu­ to the greater thickness or "retraction" ation of the uterus. of the muscle fibers of the upper than the lower segment. (This r ing is the The Anatomic and Physiologic " fundal or cornal sphincter" in the Divisions of the Uterus dog.) In obstructed labors it becomes It is important first to obtain a clear a very pronounced ring or band and concept (a) of the anatomical divisions is then called Bandl's ring. The ap­ of the human uterus, which may be pearance of a Bandl's ring means --­ traced directly to those in lower forms, threatened rupture of the uterus in the and (b) of the obstetrical or physio­ lower segment ; it is a pathological re­ logical divisions. See figure 1. traction ring. This is a subject that has been greatly III. The lower uterine segment is an­ confused because our knowledge of the alogous to the isthmus uteri oj Asch­ gross and microscopic anatomy of the off in the non-pregnant uterus. In human uterus, and of the embryology, woman its upper level is generally comparative anatomy, and physiology marked by the reflection of the per­ of the uterus has developed in ~ hap­ itoneum.
    [Show full text]